Delivery Order SPE2DB20D3103-SPE2DB25FP9W9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valganciclovir 450 mg tablets in quantities of 60 units, with a ceiling value of $12,058.08. This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 21, 2025, with fulfillment performed from AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,832.16 to AmerisourceBergen Drug Corp for the supply of Valganciclovir 450 mg tablets (60-count units) under a firm fixed price contract type. The award was made on August 25, 2025, with an ultimate completion date of August 26, 2025, and represents a competitively awarded, non-set-aside contract. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a $4,048.61 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Valganciclovir 450 mg tablets in unit dose packaging of 20s. This is a firm fixed price, competitively awarded contract with no set-aside designation and a performance location in Conshohocken, Pennsylvania. The delivery order is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Valganciclovir 450 mg tablets (60-count) under a firm fixed-price contract valued at $1,081.86. This is a non-set-aside competitive award with an ultimate completion date of September 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Valganciclovir HCl 50 mg/ml in an 88 ml formulation, with a contract ceiling value of $8,470.02 and an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Valganciclovir HCL 50 mg/ml in an 88ml unit, valued at $3,439.80 under firm fixed pricing. This delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $4,120.32 to AmerisourceBergen Drug Corp for the supply of Valganciclovir HCL 50 mg/ml in an 88ml formulation. This is a firm fixed price, non-set-aside delivery order with a completion date of September 11, 2025, issued on September 10, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 units of the medication Valganciclovir 450 mg tablets, with a ceiling value of $2,585.74 and a completion date of July 7, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,507.63, is for the delivery of 60 tablets of the medication Valganciclovir 450 mg. The contract has a firm fixed price and an ultimate completion date of November 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 450 mg valganciclovir tablets, a medication used to treat cytomegalovirus infections. The contract has a ceiling value of $2,477.97 and a performance period ending on June 17, 2025. This contract is not set aside and was competitively awarded. AmerisourceBergen...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP9W9Delivery Order
The Defense Logistics Agency awarded a $11,387.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Valganciclovir 450 mg, an antiviral medication commonly used to treat cytomegalovirus infections in immunocompromised patients. This non-set-aside competitive award was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The pharmaceutical distributor will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to military and federal healthcare systems worldwide. AmerisourceBergen's extensive federal contracting history demonstrates its capability to fulfill competitive procurement requirements and support Defense Health Agency operations, the U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to meet evolving medical supply demands.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 8/22/25 |